Nichi-Iko Pharmaceutical Co., Ltd.

Nichi-Iko Pharmaceutical Co., Ltd. Share · JP3687200000 (XTKS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Nichi-Iko Pharmaceutical Co., Ltd.
No Price
Share Float & Liquidity
Free Float 10,02 %
Shares Float 7,05 M
Shares Outstanding 70,43 M
Invested Funds

The following funds have invested in Nichi-Iko Pharmaceutical Co., Ltd.:

Fund
iShares Core MSCI Japan IMI UCITS ETF USD (Dist)
Vol. in million
16,24
Percentage (%)
0,0088 %
Fund
iShares Core MSCI Japan IMI UCITS ETF EUR Hedged (Acc)
Vol. in million
6,63
Percentage (%)
0,0088 %
Company Profile for Nichi-Iko Pharmaceutical Co., Ltd. Share
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, imports, and distributes various pharmaceutical products. The company operates through two segments, Sagent Group and Nichi-Iko Group. It primarily focuses on the production of generic drugs. The company offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products. It also provides treatments for circulatory, digestive, respiratory, central and peripheral nervous systems, and others. In addition, the company engages in the packaging design business. Further, it exports its products. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.

Company Data

Name Nichi-Iko Pharmaceutical Co., Ltd.
Company Nichi-Iko Pharmaceutical Co., Ltd.
Website https://www.nichiiko.co.jp
Primary Exchange XTKS Tokyo
ISIN JP3687200000
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Shingo Iwamoto
Market Capitalization 2 Mrd.
Country Japan
Currency JPY
Employees 2,7 T
Address 1-6-21 Sogawa, 930-8583 Toyama
IPO Date 2007-12-19
Dividends from 'Nichi-Iko Pharmaceutical Co., Ltd.'
Ex-Date Dividend per Share
29.09.2021 0,09 USD
30.03.2021 0,09 USD
29.09.2020 0,14 USD
27.03.2019 0,14 USD
26.09.2018 0,13 USD
28.03.2018 0,14 USD
27.09.2017 0,13 USD
29.03.2017 0,14 USD
28.09.2016 0,15 USD
29.03.2016 0,15 USD

Ticker Symbols

Name Symbol
Over The Counter NHKFF
Tokyo 4541.T
More Shares
Investors who hold Nichi-Iko Pharmaceutical Co., Ltd. also have the following shares in their portfolio:
DEKA        MTN IS.S.7827
DEKA MTN IS.S.7827 Bond
GRE.PAC.GOL.COR.NEW. O.N.
GRE.PAC.GOL.COR.NEW. O.N. Share